+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites



The serotonin transporter in rhesus monkey brain: comparison of DASB and citalopram binding sites



Nuclear Medicine and Biology 33(4): 555-563



We have characterized the interaction of the serotonin transporter ligand [3H]-N,N-dimethyl-2-(2-amino-4-cyanophenylthio)-benzylamine (DASB) with rhesus monkey brain in vitro using tissue homogenate binding and autoradiographic mapping. [3H]-DASB, a tritiated version of the widely used [11C] positron emission tomography tracer, was found to selectively bind to a single population of sites with high affinity (K(d)=0.20+/-0.04 nM). The serotonin transporter density (B(max)) obtained for rhesus frontal cortex was found to be 66+/-8 fmol/mg protein using [3H]-DASB, similar to the B(max) value obtained using the reference radioligand [3H]-citalopram, a well-characterized and highly selective serotonin reuptake inhibitor (83+/-22 fmol/mg protein). Specific binding sites of both [3H]-DASB and [3H]-citalopram were similarly and nonuniformly distributed throughout the rhesus central nervous system, in a pattern consistent with serotonin transporter localization reported for human brain. Regional serotonin transporter densities, estimated from optical densities of the autoradiographic images, were well correlated between the two radioligands. Finally, DASB and fluoxetine showed dose-dependent full inhibition of [3H]-citalopram binding in a competition autoradiographic study, with K(i) values in close agreement with those obtained from rhesus brain homogenates. This side-by-side comparison of [3H]-DASB and [3H]-citalopram binding sites in rhesus tissue homogenates and in adjacent rhesus brain slices provides additional support for the use of [11C]-DASB to assess the availability and distribution of serotonin transporters in nonhuman primates.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012681209

Download citation: RISBibTeXText

PMID: 16720249

DOI: 10.1016/j.nucmedbio.2006.02.007


Related references

Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteins. European Journal of Pharmacology 189(2-3): 129-134, 1990

Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain. Synapse 61(9): 724-731, 2007

The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. European Neuropsychopharmacology 15(2): 193-198, 2005

The S-enantiomer of citalopram increases inhibitor binding to the human serotonin transporter by an allosteric mechanism Comparison with other serotonin transporter inhibitors. European Neuropsychopharmacology 13(Suppl. 4): S215-S216, 2003

Dopamine transporter binding sites in fetal rhesus monkey brain Effects of gestational cocaine on -RTI-121 binding densities. Society for Neuroscience Abstracts 24(1-2): 1966, 1998

Inhibitory and regulatory binding sites on the rat brain serotonin transporter molecular weight of the tritiated paroxetine and tritiated citalopram binding proteins. European Journal of Pharmacology Molecular Pharmacology Section 3(2-3): 129-134, 1990

Serotonin transporter binding and genotype in the nonhuman primate brain using [C-11]DASB PET. Neuroimage 47(4): 1230-1236, 2009

Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. Journal of Neural Transmission 114(5): 635-639, 2007

(3)H] citalopram binding to serotonin transporter sites in minnow brains. Basic & Clinical Pharmacology & Toxicology 101(3): 203-210, 2007

Effects of repeated injections of cocaine on catecholamine receptor binding sites dopamine transporter binding sites and behavior in rhesus monkey. Brain Research 578(1-2): 235-243, 1992

Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain. Neuroimage 52(1): 50-54, 2010

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain 133(Pt 6): 1779-1797, 2010

Inhibition of [3H]citalopram binding to the rat brain serotonin transporter by Amaryllidaceae alkaloids. Planta Medica 72(5): 470-473, 2006

Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency. Biological Psychiatry 57(1): 102-106, 2005

Design and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sites. Journal of Medicinal Chemistry 56(23): 9709-9724, 2013